SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BOREA, Pier Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 50.622
AS - Asia 29.175
EU - Europa 19.862
SA - Sud America 4.429
AF - Africa 613
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 32
Totale 104.787
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 49.652
SG - Singapore 10.488
CN - Cina 7.686
DE - Germania 3.708
IT - Italia 3.451
BR - Brasile 3.419
VN - Vietnam 3.185
FI - Finlandia 3.105
UA - Ucraina 3.090
HK - Hong Kong 2.431
TR - Turchia 2.382
GB - Regno Unito 1.724
SE - Svezia 1.146
FR - Francia 1.130
RU - Federazione Russa 921
JP - Giappone 640
IN - India 600
PL - Polonia 464
MX - Messico 429
CA - Canada 418
AR - Argentina 375
BD - Bangladesh 359
NL - Olanda 288
ZA - Sudafrica 236
ID - Indonesia 231
IQ - Iraq 195
ES - Italia 171
EC - Ecuador 156
CO - Colombia 144
BE - Belgio 142
PK - Pakistan 126
VE - Venezuela 107
UZ - Uzbekistan 98
LT - Lituania 93
SA - Arabia Saudita 86
MA - Marocco 84
CL - Cile 83
CZ - Repubblica Ceca 82
PH - Filippine 78
MY - Malesia 77
TN - Tunisia 76
AT - Austria 75
AE - Emirati Arabi Uniti 72
PY - Paraguay 60
KE - Kenya 50
JO - Giordania 45
AU - Australia 43
EG - Egitto 41
IR - Iran 40
IE - Irlanda 37
IL - Israele 36
KR - Corea 36
NP - Nepal 30
DZ - Algeria 29
RO - Romania 29
UY - Uruguay 28
PE - Perù 26
TW - Taiwan 26
AZ - Azerbaigian 25
BO - Bolivia 24
AL - Albania 23
PT - Portogallo 23
CR - Costa Rica 22
KZ - Kazakistan 22
EU - Europa 21
ET - Etiopia 20
PS - Palestinian Territory 20
TH - Thailandia 20
CH - Svizzera 19
OM - Oman 18
BG - Bulgaria 16
LB - Libano 16
SN - Senegal 15
HN - Honduras 14
JM - Giamaica 14
KG - Kirghizistan 14
RS - Serbia 14
BH - Bahrain 13
PA - Panama 13
QA - Qatar 13
SY - Repubblica araba siriana 13
DO - Repubblica Dominicana 12
LV - Lettonia 11
NO - Norvegia 11
BY - Bielorussia 10
GR - Grecia 10
HR - Croazia 10
HU - Ungheria 10
AM - Armenia 9
NI - Nicaragua 9
NZ - Nuova Zelanda 9
AO - Angola 8
CI - Costa d'Avorio 8
XK - ???statistics.table.value.countryCode.XK??? 8
BA - Bosnia-Erzegovina 7
CG - Congo 7
GT - Guatemala 7
KH - Cambogia 7
KW - Kuwait 7
MD - Moldavia 7
Totale 104.638
Salva come PNG Salva come JPEG
Città #
Singapore 6.875
Ashburn 5.093
Woodbridge 4.579
Fairfield 3.673
Jacksonville 3.298
San Jose 2.937
Chandler 2.909
Houston 2.883
Ann Arbor 2.405
Hong Kong 2.380
Helsinki 2.277
Santa Clara 2.156
Beijing 2.150
Wilmington 1.659
Seattle 1.547
Dallas 1.504
Cambridge 1.158
Izmir 1.123
Ho Chi Minh City 1.072
Nanjing 1.020
Los Angeles 791
Hanoi 772
Princeton 711
Tokyo 621
Lauterbourg 559
Boardman 529
Munich 527
New York 487
Ferrara 454
Milan 438
Warsaw 401
San Diego 347
São Paulo 324
Nanchang 323
Shanghai 319
Shenyang 306
Falkenstein 290
Council Bluffs 288
Mexico City 263
Hefei 243
Orem 226
Tianjin 220
London 206
Hebei 204
Dearborn 203
Turku 194
Changsha 189
Bremen 183
Frankfurt am Main 176
San Mateo 176
Addison 170
Jiaxing 169
The Dalles 168
Chicago 163
Da Nang 155
Buffalo 152
Chennai 141
Montreal 139
Brussels 137
Brooklyn 131
Jinan 128
Haiphong 127
Rome 118
Amsterdam 117
Johannesburg 117
Jakarta 116
Falls Church 115
Zhengzhou 112
Rio de Janeiro 111
Denver 107
Toronto 105
San Francisco 102
Moscow 101
Kunming 99
Manchester 99
Guangzhou 97
Auburn Hills 94
Norwalk 94
Stockholm 89
Atlanta 88
Tashkent 88
Phoenix 86
Mountain View 85
Baghdad 80
Ningbo 80
Bologna 79
Philadelphia 79
Poplar 78
Boston 75
Mumbai 72
Florence 70
Belo Horizonte 67
Ankara 64
Biên Hòa 63
Düsseldorf 63
Orange 63
Redwood City 63
Hải Dương 58
Verona 57
Des Moines 56
Totale 68.755
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.087
Farmacologia cellulare e molecolare, sistemi di trasmissione e autacoidi. Trasmissione purinergica 1.382
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 402
Progetto ex 60%- I recettori dell’adenosina come possibili “biomarkers” dei tumori colorettali. Studio su tessuti umani sani e tumorali e sulle cellule del sangue periferico. 393
Pharmacology of Adenosine Receptors: The State of the Art 381
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 328
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 308
A glance at adenosine receptors: Novel target for antitumor therapy 304
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 293
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 285
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 283
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 281
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 278
The A3 adenosine receptor: history and perspectives 275
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 273
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 273
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 271
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 262
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 259
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 258
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 257
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 255
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 255
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 255
Adenosine receptors and human melanoma 253
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 252
Recettori e trasduzione del segnale 249
7-Chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine (medazepam) 248
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 245
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 244
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 244
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 243
Recettori e trasduzione del segnale 240
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 239
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 239
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 238
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 237
Ala scan analogues of HOE 140. Synthesis and biological activities 237
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 236
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 235
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 234
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 234
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 234
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 232
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 231
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 229
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 228
2 Aralkynyl and 2-heteroalkynyl derivatives of adenosine 5'-N-ethyluronamide as selective A2A adenosine receptor agonists 227
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 227
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 226
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 226
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 225
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 224
7-nitro-1,3-dihydro-5-phenyl-1,4-benzodiazepin-2-one (nitrazepam) 224
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells 224
Comparison of prazosin, terazosin and tamsulosin: Functional and binding studies in isolated prostatic and vascular human tissues 221
Adenosine receptors and cancer 221
Adenosine receptor targeting in health and disease 221
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 220
Adenosine signaling contributes to ethanol-induced fatty liver in mice 220
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 220
Octadecyl, phenyl and cyano phases comparison for the RP-HPLC prediction of octanol-water partition coefficient 219
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 219
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 219
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 218
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: Synthesis and affinity at 5-HT(2A), 5-HT(2B) and 5- HT(2C) serotonin receptors 218
5-heteroarylcarbamoylamino-pyrazolo-triazolo pyrimidines as hA3 adenosine receptor antagonists. 217
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 217
van't Hoff Based Thermodynamics 216
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 216
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 215
Current status of A1 adenosine receptor allosteric enhancers 215
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 214
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2 214
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 214
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 213
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 212
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 212
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 211
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 211
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 211
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 210
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 210
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 210
Agonists and antagonists: Molecular mechanisms and therapeutic applications 210
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 209
7-substituted-5-amino-2-(furyl)-pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: importance of modifications at the side chain on the activity and solubility. 209
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 208
Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells 208
3H SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes 208
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 208
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 208
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 207
Microwave-assisted synthesis of thieno[2,3-c]pyridine derivatives as a new series of allosteric enhancers at the adenosine A(1) receptor 207
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 207
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 206
7-substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A(2A) adenosine receptor antagonists: A study on the importance of modifications at the side chain on the activity and solubility 206
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 205
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 205
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 204
Totale 27.771
Salva come PNG Salva come JPEG
Categoria #
all - tutte 421.782
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 16.218
Totale 438.000
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.623 0 0 0 0 0 0 0 0 0 1.054 1.109 460
2021/20226.405 141 667 443 343 406 252 229 321 245 500 823 2.035
2022/20236.799 720 418 200 898 1.133 1.042 273 566 876 53 372 248
2023/20243.370 354 442 175 97 353 386 183 242 66 101 107 864
2024/202513.457 395 383 1.062 633 1.646 1.192 406 904 1.847 1.522 1.911 1.556
2025/202638.267 3.833 1.684 3.942 4.949 5.365 2.610 4.561 1.952 5.516 3.855 0 0
Totale 105.429